Latest news
Latigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTCardiac drug developer Braveheart banks more than $382M in IPO - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 03:18:37 GMTAttovia adds to biotech IPO momentum with $289M offering - BioPharma DiveBioPharma Dive · Wed, 05 Aug 2026 16:19:45 GMT